LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of software for pharmaceutical discovery and development, today released preliminary revenues for its second fiscal quarter ended February 28, 2010, and announced that it has filed an amendment to its Annual Report on Form 10K for its fiscal year 2009 with the Securities and Exchange Commission (SEC) in response to comments by the SEC regarding that report.

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today announced that it has retained Hayden IR, a national, New York-based investor relations consulting firm, to develop an investor relations program to raise the company’s visibility and strengthen its relationships with the investment community.

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announces the launch of a new product that will assist pharmaceutical scientists in estimating the effects of physiological fluids on the solubility of drug-like molecules.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP - News), the leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today that its board of directors has authorized a renewed share repurchase program effective Monday, February 15, 2010.

LANCASTER, CA, January 13, 2010 – Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported financial results for its first quarter of fiscal year 2010 ended November 30, 2009 (1QFY10).

LANCASTER, CA, January 12, 2010 – Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its Form 10-Q quarterly report with the Securities and Exchange Commission on Tuesday, January 12, for the first quarter of its 2010 fiscal year ended November 30, 2009. Chairman and CEO Walt Woltosz will host a conference call and webinar to discuss the Company’s performance on Wednesday afternoon, January 13, at 1:15 PM PST / 4:15 PM EST.

LANCASTER, CA, December 16, 2009 – Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software to the pharmaceutical industry, announces the appointment of Mr. John DiBella as manager of marketing and sales, reporting to Dr. Michael Pelekis, director of business development, marketing, and sales.

LANCASTER, CA, December 10, 2009 – Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software to the pharmaceutical industry, announces the appointment of Robert D. Clark, Ph.D., to the position of Director, Life Sciences.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP - News), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announces the launch of a new product for the popular iPhone based on its long-standing Abbreviate! software for personal computers.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP - News), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2009 fiscal year (FY09) ended August 31, 2009.